Search

Displaying results 4431 - 4440 of 7603 in total
  1. Drug

    Modufolin

    go.drugbank.com/drugs/DB12676
    Investigational

    Modufolin is under investigation for the treatment of Osteosarcoma.

  2. Drug

    ABT-560

    go.drugbank.com/drugs/DB06093
    Experimental

    ABT-560 is a neuronal nicotinic receptor (NNR) modulator, which has shown promise in preclinical models relevant for the treatment of cognitive deficits.

  3. Drug

    ATG003

    go.drugbank.com/drugs/DB05069
    Investigational

    ATG003, a novel anti-angiogenic drug candidate and a formulation of mecamylamine, is currently in clinical development for neovascular age-related macular degeneration.

  4. Drug

    Talinolol

    go.drugbank.com/drugs/DB11770
    Investigational

    Talinolol has been investigated for the basic science of Gastrointestinal Motility Disorder.

  5. Drug

    APG-157

    go.drugbank.com/drugs/DB18683
    InvestigationalNutraceutical

    APG-157 consists of zinflavonoids being investigated for the treatment of cancers.

  6. Drug

    Roniciclib

    go.drugbank.com/drugs/DB12974
    Investigational

    Roniciclib has been investigated for the treatment of Small Cell Lung Carcinoma.

  7. Drug

    Talarozole

    go.drugbank.com/drugs/DB13083
    Investigational

    Talarozole has been investigated for the treatment of Psoriasis and Cutaneous Inflammation.

  8. Drug

    Teneligliptin

    go.drugbank.com/drugs/DB11950
    Investigational

    Teneligliptin has been investigated for the treatment of Type 2 Diabetes Mellitus.

  9. Drug

    GSK-2018682

    go.drugbank.com/drugs/DB11987
    Investigational

    GSK2018682 has been investigated for the treatment of Multiple Sclerosis, Relapsing-Remitting.

  10. Drug

    RTX-117

    go.drugbank.com/drugs/DB28443
    Experimental

    RTX-117 is being investigated for Charcot-Marie-Tooth disease (CMT).[L54166]